Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Abstract 1099: Combined MEK and RET inhibition overcomes resistance to single agent RET inhibition in medullary thyroid cancer

Arwa Fallatah, Abdelrahman Rahmy, Sophia Khan, Hsien-chao Chou, Kerstin Heselmeyer-Haddad, Darawalee Wangsa, David Milewski, Yong Kim, Robert Hawley, Young Song, Xiaohu Zhang, Craig Thomas, Jun S. Wei, Jong-In Park, John Glod, Javed Khan

Cancer Res (2024) 84 (6_Supplement): 1099.

https://doi.org/10.1158/1538-7445.AM2024-1099

Published: 22 March 2024

View articletitled, Abstract 1099: Combined MEK and RET inhibition overcomes resistance to single agent RET inhibition in medullary thyroid cancer

Journal Articles

Abstract 5835: Genome-Wide CRISPR gene knockout screens combined with selpercatinib identifies potent combination therapies for RET driven medullary thyroid carcinoma

Abdelrahman Rahmy, Arwa Fallatah, David Milewski, Meijie Tian, Young Song, Yong Kim, Hsien-Chao Chou, Xinyu Wen, Chaoyu Wang, Jun Wei, Robert Hawley, John Glod, Javed Khan

Cancer Res (2024) 84 (6_Supplement): 5835.

https://doi.org/10.1158/1538-7445.AM2024-5835

Published: 22 March 2024

View articletitled, Abstract 5835: Genome-Wide CRISPR gene knockout screens combined with selpercatinib identifies potent combination therapies for RET driven medullary thyroid carcinoma

Journal Articles

Abstract 2142: Immune determinants of CAR-T expansion in solid tumor patients receiving GD2 CAR-T cell therapy

Cancer Res (2023) 83 (7_Supplement): 2142.

https://doi.org/10.1158/1538-7445.AM2023-2142

Published: 04 April 2023

View articletitled, Abstract 2142: Immune determinants of CAR-T expansion in solid tumor patients receiving GD2 CAR-T cell therapy

Journal Articles

Abstract CT142: GD2.Ox40.CD28.z CAR T cell trial in neuroblastoma and osteosarcoma

Cancer Res (2022) 82 (12_Supplement): CT142.

https://doi.org/10.1158/1538-7445.AM2022-CT142

Published: 15 June 2022

View articletitled, Abstract CT142: GD2.Ox40.CD28.z CAR T cell trial in neuroblastoma and osteosarcoma

Journal Articles

MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

Konstantinos V. Floros, JinYang Cai, Sheeba Jacob, Richard Kurupi, Carter K. Fairchild, Mayuri Shende, Colin M. Coon, Krista M. Powell, Benjamin R. Belvin, Bin Hu, Madhavi Puchalapalli, Sivapriya Ramamoorthy, Kimberly Swift, Janina P. Lewis, Mikhail G. Dozmorov, John Glod, Jennifer E. Koblinski, Sosipatros A. Boikos, Anthony C. Faber

Cancer Res (2021) 81 (7): 1896–1908.

https://doi.org/10.1158/0008-5472.CAN-20-1641

Published: 01 April 2021

View articletitled, MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

Includes: Supplementary data

Journal Articles

Abstract PO-024: Catastrophic ATP loss underlines a metabolic combination therapy tailored for MYCN-amplified neuroblastoma

Cancer Res (2020) 80 (23_Supplement): PO-024.

https://doi.org/10.1158/1538-7445.EPIMETAB20-PO-024

Published: 02 December 2020

View articletitled, Abstract PO-024: Catastrophic ATP loss underlines a metabolic combination therapy tailored for MYCN-amplified neuroblastoma

Journal Articles

Abstract 2943: Severe hepatotoxicity of mithramycin therapy caused by altering expression of hepatocellular bile transporters

Tristan M. Sissung, Phoebe A. Huang, Ralph Hauke, Edel McCrea, Cody J. Peer, Roberto H. Barbier, Jonathan D. Strope, Ariel M. Ley, Mary Zhang, Julie A. Hong, David Venzon, Jonathan P. Jackson, Kenneth R. Brouwer, Patrick Grohar, John Glod, Brigitte C. Widemann, Theo Heller, David S. Schrump, William D. Figg

Cancer Res (2019) 79 (13_Supplement): 2943.

https://doi.org/10.1158/1538-7445.AM2019-2943

Published: 01 July 2019

View articletitled, Abstract 2943: Severe hepatotoxicity of mithramycin therapy caused by altering expression of hepatocellular bile transporters

Journal Articles

Abstract 540: Lactate as a mediator of mesenchymal stem cell interactions within the tumor microenvironment

Yanique I. Rattigan, Alister F. Martin, John Glod, Debabrata Banerjee

Cancer Res (2010) 70 (8_Supplement): 540.

https://doi.org/10.1158/1538-7445.AM10-540

Published: 15 April 2010

View articletitled, Abstract 540: Lactate as a mediator of mesenchymal stem cell interactions within the tumor microenvironment

Journal Articles

Abstract 556: Extracellular matrix protein mixture isolated from cultures of human tumor and stromal cells supports growth of human tumor cells in vitro and in vivo

Pravin J. Mishra, Prasun J. Mishra, Hui Gao, John Glod, Debabrata Banerjee

Cancer Res (2010) 70 (8_Supplement): 556.

https://doi.org/10.1158/1538-7445.AM10-556

Published: 15 April 2010

View articletitled, Abstract 556: Extracellular matrix protein mixture isolated from cultures of human tumor and stromal cells supports growth of human tumor cells in vitro and in vivo

Journal Articles

Abstract #1107: Role of IL-6 and hypoxia in mesenchymal stem cell migration towards tumor cells

Yanique Rattigan, John Glod, Debabrata Banerjee

Cancer Res (2009) 69 (9_Supplement): 1107.

Published: 01 May 2009

View articletitled, Abstract #1107: Role of IL-6 and hypoxia in mesenchymal stem cell migration towards tumor cells

Journal Articles

Abstract #332: Tumor-associated macrophages induce tumor growth and chemoresistant properties in glioblastoma: a role for interleukin-6

Kevin Anton, Debabrata Banerjee, John Glod

Cancer Res (2009) 69 (9_Supplement): 332.

Published: 01 May 2009

View articletitled, Abstract #332: Tumor-associated macrophages induce tumor growth and chemoresistant properties in glioblastoma: a role for interleukin-6

Journal Articles

Abstract #1132: Reconstituting the tumor milieu to study tumor stroma interaction

Pravin Mishra, Hui Gao, Sonia Picinich, John Glod, Debabrata Banerjee

Cancer Res (2009) 69 (9_Supplement): 1132.

Published: 01 May 2009

View articletitled, Abstract #1132: Reconstituting the tumor milieu to study tumor stroma interaction

Journal Articles

Targeting stromal cells in the tumor microenvironment: utility of the connectivity map

Prasun Mishra, Pravin Mishra, Rita Humeniuk, Gabriela Alexe, Jose Jimeno, Miguel Aracil, Joseph Bertino, John Glod, Debabrata Banerjee

Cancer Res (2008) 68 (9_Supplement): 3707.

Published: 01 May 2008

View articletitled, Targeting stromal cells in the tumor microenvironment: utility of the connectivity map

Journal Articles

Migration of mesenchymal stem cells to tumor cells under hypoxia

Yanique Rattigan, Sonia Picinich, John Glod, Debabrata Banerjee

Cancer Res (2008) 68 (9_Supplement): 2056.

Published: 01 May 2008

View articletitled, Migration of mesenchymal stem cells to tumor cells under hypoxia

Journal Articles

Mesenchymal stem cells express markers of myofibroblast lineage after long term exposure to conditioned medium from tumor cells

Pravin Mishra, Prasun Mishra, Rita Humeniuk, John Glod, Debabrata Banerjee

Cancer Res (2007) 67 (9_Supplement): 572.

Published: 01 May 2007

View articletitled, Mesenchymal stem cells express markers of myofibroblast lineage after long term exposure to conditioned medium from tumor cells

Journal Articles

The JAK2/STAT3- mediated SDF-1/CXCR4 axis promotes mesenchymal stem cell migration in response to the tumor microenvironment.

Hui Gao, Rajeth Koneru, John Glod, Debabrata Banerjee

Cancer Res (2007) 67 (9_Supplement): 573.

Published: 01 May 2007

View articletitled, The JAK2/STAT3- mediated SDF-1/CXCR4 axis promotes mesenchymal stem cell migration in response to the tumor microenvironment.

Journal Articles

Investigating the role of tumor-secreted factors in chemotaxis of mesenchymal stem cells to the tumor microenvironment.

Debabrata Banerjee, Sonia Picinich, John Glod

Cancer Res (2007) 67 (9_Supplement): 540.

Published: 01 May 2007

View articletitled, Investigating the role of tumor-secreted factors in chemotaxis of mesenchymal stem cells to the tumor microenvironment.

Journal Articles

Hepatoma-derived growth factor is a tumor-derived mesenchymal stem cell chemoattractant

Siang-Yo Lin, Barton Kamen, Debabrata Banerjee, John Glod

Cancer Res (2007) 67 (9_Supplement): 575.

Published: 01 May 2007

View articletitled, Hepatoma-derived growth factor is a tumor-derived mesenchymal stem cell chemoattractant

Journal Articles

LPS-stimulated macrophages induce chemotaxis of mesenchymal stem cells

Kevin Anton, Stephanie Veerasammy, Sonia Picinich, Debabrata Banerjee, John Glod

Cancer Res (2007) 67 (9_Supplement): 556.

Published: 01 May 2007

View articletitled, LPS-stimulated macrophages induce chemotaxis of mesenchymal stem cells

Journal Articles

Characterization of cellular signals released by tumor cells that promote migration of mesenchymal stem cells to the tumor microenvironment

Sonia C. Picinich, Lata G. Menon, Rajeth Koneru, Mythili Koneru, Philipp Mayer-Kuckuk, John Glod, Debabrata Banerjee

Cancer Res (2006) 66 (8_Supplement): 773.

Published: 15 April 2006

View articletitled, Characterization of cellular signals released by tumor cells that promote migration of mesenchymal stem cells to the tumor microenvironment

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 1099: Combined MEK and RET inhibition overcomes resistance to single agent RET inhibition in medullary thyroid cancer

Abstract 5835: Genome-Wide CRISPR gene knockout screens combined with selpercatinib identifies potent combination therapies for RET driven medullary thyroid carcinoma

Abstract 2142: Immune determinants of CAR-T expansion in solid tumor patients receiving GD2 CAR-T cell therapy

Abstract CT142: GD2.Ox40.CD28.z CAR T cell trial in neuroblastoma and osteosarcoma

MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

Abstract PO-024: Catastrophic ATP loss underlines a metabolic combination therapy tailored for MYCN-amplified neuroblastoma

Abstract 2943: Severe hepatotoxicity of mithramycin therapy caused by altering expression of hepatocellular bile transporters

Abstract 540: Lactate as a mediator of mesenchymal stem cell interactions within the tumor microenvironment

Abstract 556: Extracellular matrix protein mixture isolated from cultures of human tumor and stromal cells supports growth of human tumor cells in vitro and in vivo

Abstract #1107: Role of IL-6 and hypoxia in mesenchymal stem cell migration towards tumor cells

Abstract #332: Tumor-associated macrophages induce tumor growth and chemoresistant properties in glioblastoma: a role for interleukin-6

Abstract #1132: Reconstituting the tumor milieu to study tumor stroma interaction

Targeting stromal cells in the tumor microenvironment: utility of the connectivity map

Migration of mesenchymal stem cells to tumor cells under hypoxia

Mesenchymal stem cells express markers of myofibroblast lineage after long term exposure to conditioned medium from tumor cells

The JAK2/STAT3- mediated SDF-1/CXCR4 axis promotes mesenchymal stem cell migration in response to the tumor microenvironment.

Investigating the role of tumor-secreted factors in chemotaxis of mesenchymal stem cells to the tumor microenvironment.

Hepatoma-derived growth factor is a tumor-derived mesenchymal stem cell chemoattractant

LPS-stimulated macrophages induce chemotaxis of mesenchymal stem cells

Characterization of cellular signals released by tumor cells that promote migration of mesenchymal stem cells to the tumor microenvironment

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only